Clorox Total 360 – Ultimate Disinfecting System Cleans Where Others Don’t

adminFacility Maintenance, Health/Safety

Clorox Total 360 System - Hospitals

Clorox Professional Products Company introduced the Clorox Total 360 System to the commercial cleaning market. This surface treatment system, recently awarded the professional cleaning industry’s top honor, uses patented electrostatic technology to reach even the hardest-to-reach places with trusted Clorox products.

Think about all the nooks and crannies you’ll find in a hospital or school or a gym that can harbor illness-causing germs. The Clorox Total 360 System makes it significantly easier to reach surfaces outside the line of sight, covering what conventional trigger sprays can miss, including the sides, underside and backside of surfaces, making it significantly easier and more cost effective to keep surfaces disinfected and sanitized in busy places like hospitals, schools, offices, athletic facilities and food service settings.”

The Clorox Total 360 System, which can cover up to 18,000-square feet per hour with Clorox Commercial Solutions Clorox Total 360 Disinfectant Cleaner, was recently voted the 2017 ISSA Innovation of the Year Award and Visitors’ Choice Award winner by the professional cleaning industry.

“The ISSA Innovation Award Program celebrates innovations that are helping to drive the professional cleaning industry forward,” said Lou Centrella, the worldwide cleaning industry association ISSA’s Director of Digital Media. “This was one of our most competitive years with a pool of 44 entries from 38 companies, and we proudly congratulate each of this year’s winners.”

The Clorox Total 360 System is the company’s fourth product to be recognized by ISSA’s Innovation Award Program. It’s introduction to the market by Clorox Professional Products Company, comes just in time for flu season.

Fighting illnesses and infections – and not just during flu season
Nearly 1.5 million workdays are lost each year due to the flu, which adds up to over $1 billion in lost productivity.1 Antibiotic-resistant bacteria like methicillin-resistant Staphylococcus aureus (MRSA) is also a concern in long term care, education and athletic facilities, as well as in emergency response settings where shared equipment or supplies and skin-to-skin contact may increase the risk of MRSA and other infections.2 Since illness-causing germs can survive on surfaces for extended periods, facilities need to be confident that their cleaning and disinfecting protocols can get the job done.

Clorox Commercial Solutions Clorox Total 360 Disinfectant Cleaner kills 18 illness-causing organisms in two minutes or less. The ready-to-use, one-step disinfectant cleaner eliminates odors and kills outbreak-causing viruses like influenza, rhinovirus and norovirus and MRSA and Vancomycin Resistant Enterococcus faecium (VRE). The non-bleach-based formula is specifically designed for broad surface compatibility, making it ideal for use on a wide variety of surfaces.

Electrostatic technology: A force stronger than gravity
The Clorox Total 360 System’s electrostatic spray technology uses an electrode to introduce an attractive charge to the disinfecting product. An air compressor atomizes the solution and generates a quiet, but powerful liquid flow. The solution’s charged particles are attracted to surfaces with a force stronger than gravity, allowing the solution to reach and uniformly coat even hard-to-reach surfaces. These particles also clear the air faster versus foggers, allowing people to re-enter a room much sooner.

“Safety, efficacy and aesthetic concerns like surface compatibility and residue are always key considerations in our product development,” said Brian Thompson, department manager – Clorox Research and Development. The Clorox Total 360 System was designed to enhance surface coverage and reduce the time it takes to treat surfaces in large facilities.

For more information about the Clorox Total 360 System go here.

1 Keech, M, et al. “The impact of influenza on working days lost: a review of the literature.” Pharmacoeconomics. 2008;26(11):911-24.
2 “General Information About MRSA in the Community.” Centers for Disease Control and Prevention, Mar. 25, 2016. (Accessed March 7, 2017).